NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
26.67
-1.16 (-4.17%)
At close: Aug 13, 2026, 4:00 PM EDT
27.20
+0.53 (1.99%)
After-hours: Aug 13, 2026, 7:34 PM EDT

NAMS Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, NAMS stock has a consensus rating of "Strong Buy" and an average price target of $51.25. The average 1-year stock price forecast is 92.16% higher than the current stock price, while the lowest is $37.92 (+42.18%) and the highest is $59.87 (+124.48%).

Price Target: $51.25 (+92.16%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$37.92$51.25$51.89$59.87
Change+42.18%+92.16%+94.56%+124.48%

Analyst Ratings

The average analyst rating for NAMS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy111111111212
Buy333333
Hold111111
Sell000000
Strong Sell000000
Total151515151616

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Needham
Needham
Buy
Maintains
$48
BuyMaintains$48+79.98%Aug 7, 2026
Truist Financial
Truist Financial
Buy
Reiterates
n/a
BuyReiteratesn/an/aAug 6, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Reiterates
$50
BuyReiterates$50+87.48%Aug 6, 2026
BMO Capital
BMO Capital
Buy
Reiterates
$58
BuyReiterates$58+117.47%Aug 6, 2026
William Blair
William Blair
Buy
Reiterates
n/a
BuyReiteratesn/an/aAug 6, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
29.17M
from 22.50M
Increased by 29.63%
Revenue Next Year
144.50M
from 29.17M
Increased by 395.36%
EPS This Year
-1.97
from -1.72
EPS Next Year
-1.57
from -1.97
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-102.69M14.09M45.56M22.50M29.17M
Revenue Growth
---86.28%223.37%-50.61%29.63%
Gross Profit
-102.69M14.09M45.56M22.50M29.17M
Gross Margin
-100.00%100.00%100.00%100.00%100.00%
Operating Income
-34.98M-3.56M-182.97M-176.29M-225.68M-259.49M
Net Income
-41.79M-22.63M-176.94M-241.60M-203.82M-242.33M
EPS
-----1.72-1.97
Free Cash Flow
-15.94M22.70M-72.00M-43.17M-112.91M-154.92M
No. Analysts
-----16
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High47.9M
Avg29.2M
Low6.9M

Revenue Growth

Revenue Growth202620272028
High
113.0%
Avg
29.6%
Low
-69.5%

EPS Forecast

EPS202620272028
High-1.69
Avg-1.97
Low-2.21

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-